中文 | English
Return
Total: 91 , 1/10
Show Home Prev Next End page: GO
Author:(Hong-ran WU)

1.Baicalin inhibits PDK1 to mediate glucose metabolism reprogramming and intervene rheumatoid arthritis synovial inflammation

Yu-long ZHU ; Yan-hong BU ; Ran DENG ; Yan WANG ; Pei-rong GAN ; Hong WU

Acta Pharmaceutica Sinica 2023;58(5):1165-1172

2.Assessment of myocardial viability by three-dimensional speckle tracking echocardiography

Hong RAN ; Pingyang ZHANG ; Youxiang ZHANG ; Jianxin ZHANG ; Wenfang WU ; Jing DONG ; Xiaowu MA

Chinese Journal of Emergency Medicine 2014;23(7):752-757

3.Effects of sphingosine-1-phosphate andits receptors on angiogenesis in autoimmune diseases

Zhengrong ZHANG ; Hong WU ; Li DAI ; Wenyu WANG ; Ran DENG ; Feng LI ; Jun FU

Chinese Pharmacological Bulletin 2017;33(9):1190-1194

4.Scoliosis on pulmonary function.

Hao RAN ; Wu ZHI-HONG ; Han JIANG-NA

Acta Academiae Medicinae Sinicae 2011;33(1):102-106

6.The role of coupler perfusion in transrectal ultrasound in the diagnosis of T-stage rectal cancer

Guozhu WU ; Yanwei GAO ; Hua HONG ; Yumin WANG ; Xianyan MENG ; Ran SUN ; Qian LIU ; Haijun LI ; Danyan LIANG

Chinese Journal of Ultrasonography 2021;30(2):151-156

8.Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients.

Hong-Tuan ZHANG ; Yong XU ; Ji-Wu CHANG ; Zhi-Hong ZHANG ; Ran-Lu LIU ; Bao-Jie MA

National Journal of Andrology 2012;18(3):208-211

9.The effects of compound CX09040 on the inhibition of PTP1B and protection of pancreatic β cells.

Ran-qi TANG ; Xiao-lin ZHANG ; Jin-ying TIAN ; Si-ming KONG ; Ying ZHOU ; Pei ZHANG ; Hong-kun YANG ; Song WU ; Ying ZHANG ; Fei YE

Acta Pharmaceutica Sinica 2015;50(6):682-689

10.Study on promoter methylation status of E-cadherin gene in nasopharyngeal carcinoma cell lines.

Chao-qun HONG ; Yong-gang RAN ; Jiong-yu CHEN ; Xiao WU ; Yan-jie YOU

Chinese Journal of Pathology 2010;39(8):532-536

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 91 , 1/10 Show Home Prev Next End page: GO